Hennion & Walsh Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,531
Closed -$621K 954
2025
Q2
$621K Sell
9,531
-886
-9% -$53.1K 0.03% 611
2025
Q1
$643K Sell
10,417
-6,380
-38% -$423K 0.03% 577
2024
Q4
$1.21M Sell
16,797
-343
-2% -$26.8K 0.05% 421
2024
Q3
$1.4M Sell
17,140
-274
-2% -$21.9K 0.07% 375
2024
Q2
$1.29M Sell
17,414
-260
-1% -$19.5K 0.07% 364
2024
Q1
$1.38M Buy
17,674
+509
+3% +$37.9K 0.07% 342
2023
Q4
$1.23M Buy
17,165
+2,539
+17% +$177K 0.07% 357
2023
Q3
$1.02M Buy
14,626
+8,089
+124% +$611K 0.06% 355
2023
Q2
$529K Buy
6,537
+1,223
+23% +$99.9K 0.03% 491
2023
Q1
$429K Buy
+5,314
New +$428K 0.03% 536

Other funds holding HOLX

Hennion & Walsh Asset Management's HOLX Position: Q3 2025 in Review

Hennion & Walsh Asset Management sold out of Hologic (HOLX) in Q3 2025, closing a stake of 9,531 shares — an estimated $621K sold.

Hennion & Walsh Asset Management first reported a position in HOLX in Q1 2023 and held it in 10 quarters. The position peaked at $1.4M in Q3 2024. 739 funds tracked by Wall St. Rank hold HOLX as of Q3 2025.

  • Hennion & Walsh Asset Management reported no remaining Hologic position as of Q3 2025 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 9,531 Hologic shares in Q3 2025, an estimated $621K.
  • Hennion & Walsh Asset Management first reported a position in Hologic in Q1 2023 and held it in 10 quarters.
  • Hennion & Walsh Asset Management's Hologic position peaked at $1.4M in Q3 2024.
  • 739 funds tracked by Wall St. Rank held Hologic as of Q3 2025.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2025, filed 22 Oct 2025.